February 4th 2025
Developers save money and time while accessing expertise.
February 3rd 2025
The optimization of processes for the development and manufacture of biopharmaceuticals is pivotal for producing quality products.
January 16th 2025
The manufacturing agreement is expected to run through December 2030, subject to change, with production to take place at Samsung Biologics’ Songdo, South Korea, site.
December 27th 2024
Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.
December 20th 2024
Contract development and manufacturing organizations (CDMOs) are more critical than ever as the demand for advanced therapies continues to grow.
There are considerations companies may want to consider before seeking out a service provider.
Where Automation Meets Skill Set
A look at the skill sets and training needed to tackle the increasing levels of automation in bioprocessing facilities.
Lonza Strengthens Cell Capabilities
The company has launched a comprehensive portfolio of custom cell biology solutions and a new cell-line engineering technology.
MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies
Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.
Thermo Fisher Scientific to Acquire Brammer Bio
A $1.7-billion acquisition CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.
Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing
The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.
Thermo Fisher Scientific Adds Aseptic Capacity
The Pharma Services business of Thermo Fisher Scientific will invest $150 Million at three facilities.
Fujifilm to Acquire Large-Scale Biologics Manufacturing Site from Biogen in $890-Million Deal
The acquisition of the site in Copenhagen, Denmark, will significantly expand Fujifilm’s capacity and capabilities.
Strategic Ventures Reflect Dynamic Growth in China
Technology vendors are strengthening their positions in China as the nation emphasizes self-sufficiency in research, development, and manufacturing.
CMOs Leading the Way on Single-Use Systems Adoption
Single-use systems can be a cost savings for CMOs, and these savings can be passed on to clients and, ultimately, to patients.
The Expanding Landscape of Commercial Single-Use Bioreactors
A look at recent investments by contract manufacturers to increase single-use bioreactor capacity.
Maselli Named President, COO of Catalent
Catalent adds position of president and chief operating officer to lead sales and quality efforts.
Federal Court Enters Consent Decree Against Compounder
The US District Court for the Western District of Pennsylvania entered into a consent decree of permanent injunction against Ranier’s Rx Laboratory Inc., a compounding facility.
PCI Pharma Services Expands Bottling Capacity
PCI Pharma Services expanded capacity of its commercial packaging site in Illinois.
Dr. Reddy’s Embarks on New Quality Improvement Programs
Radha Iyer, vice-president and head of Quality and Scientific Affairs, Global Developed Markets, Dr. Reddy’s Laboratories, discusses new initiatives at the company.
IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Company launches new services dedicated to emerging biotech and biopharma companies.
Supply Chain Challenges for Single-Use Systems
Suppliers address the complexity of supplying disposable components for single-use systems to the global biopharmaceutical manufacturing industry.
Sustainability in Disposal of Single-Use Systems
Single-use components for biopharmaceutical manufacturing have a lower environmental impact than reusable components, but disposal is still a consideration.
SGS Expands Testing Capabilities at Its Glasgow Facility
SGS announces expansion of cell bank and bulk harvest testing services.
Lonza Names New CEO
CDMO leader Marc Funk will succeed Ridinger as CEO of Lonza.
Catalent Invests $200 Million in Wisconsin and Indiana Sites
The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.
Fujifilm Invests in Biopharmaceutical Production Capacity
Fujifilm increases capacity of its Bio-CDMO business with an expansion of production in North Carolina.
Rentschler Biopharma Completes Acquisition of US Manufacturing Site
The Massachusetts site, formerly associated with an affiliate of Shire, is Rentschler Biopharma’s first facility in the US.
The Outlook for CMO Outsourcing in 2019
Outsourcing of manufacturing activities is expected to increase in 2019.
Catalent Expands Biologics Packaging Capabilities at Indiana Site
The company is investing approximately $14 million to expand biologics packaging capabilities and capacity at its biologics manufacturing facility in Bloomington, IN.
Contract Organizations Expanded in Autumn
CMOs and CDMOs made investments in new and expanded facilities and services in the last quarter of 2018.
Going Beyond the Surface to Ensure Supplier Quality
Success depends on supplier communication and transparency, but it’s up to buyers to demand the right information and to look at the vendor’s overall business.
ADC Bio Secures Additional Equity Round Investment
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.
Lonza Expands Parenteral Dosage Form Capabilities
The expansion adds new capabilities and enhances existing service offerings for both oral and parenteral dosage forms.
Innovation and Industry Strength Recognized at CPhI
Survey results and record attendance may show positive signs for established and emerging biopharma regions.
Single-Use Bioprocessing Equipment Trends and Adoption by CMOs
The growth in adoption of single-use systems for commercial manufacturing will be dramatic in coming years.